BETA-LACTAMASES OF MORAXELLA-CATARRHALIS

被引:6
|
作者
CULLMANN, W
机构
[1] F. Hoffmann-La Roche Ltd, CH 4002 Basel
来源
关键词
MORAXELLA-CATARRHALIS; BETA-LACTAMASES; SENSITIVITY TO ANTIBIOTICS; CLINICAL RELEVANCE OF BETA-LACTAMASES; OUTER MEMBRANE PROTEINS;
D O I
10.1016/S0399-077X(05)80865-0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The enzymes called BRO-1 (formerly called "Ravasio-type") and BRO-2 (formerly called "1908-type") are the most predominantly observed beta-lactamases in clinical Moraxella catarrhalis isolates. Both of these enzymes can be observed on a worldwide scale, whereas other enzymes occur infrequently. The first beta-lactamase producing (bla+) isolate was detected in clinical specimens in 1976; at present however, 70 to 90 % of all clinical isolates are bla+. These enzymes are most likely transposon-mediated and can be observed in other members of the Moraxella family. The molecular weight ot the BRO-1 enzyme amounts to 33 kdal; it hydrolyses the penicillin derivatives very rapidly, to a lesser extent the older cephalosporins; however, the latter ones exhibit low affinity to the enzyme.
引用
收藏
页码:529 / 534
页数:6
相关论文
共 50 条
  • [1] Moraxella catarrhalis: Clinical significance, antimicrobial susceptibility and BRO beta-lactamases
    K. McGregor
    B. J. Chang
    B. J. Mee
    T. V. Riley
    European Journal of Clinical Microbiology and Infectious Diseases, 1998, 17 : 219 - 234
  • [2] The beta-lactamases of Moraxella (Branhamella) catarrhalis isolated from Danish children
    Ejlertsen, T
    Skov, R
    APMIS, 1996, 104 (7-8) : 557 - 562
  • [3] Moraxella catarrhalis: Clinical significance, antimicrobial susceptibility and BRO beta-lactamases
    McGregor, K
    Chang, BJ
    Mee, BJ
    Riley, TV
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1998, 17 (04) : 219 - 234
  • [4] Antimicrobial resistance and production of beta-lactamases in Bulgarian clinical isolates Moraxella catarrhalis
    Gergova, Raina
    Markovska, Rumyana
    Mitov, Ivan
    ANNALS OF MICROBIOLOGY, 2009, 59 (01) : 169 - 172
  • [5] EXTRACTION OF BETA-LACTAMASE FROM MORAXELLA-CATARRHALIS
    FUNG, CP
    YEO, SF
    LIVERMORE, DM
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (01) : 183 - 184
  • [6] THE BETA-LACTAMASES OF BRANHAMELLA-CATARRHALIS
    WALLACE, RJ
    HOLLIS, D
    WEAVER, R
    STEINGRUBE, V
    FLANAGAN, C
    LABIDI, A
    NASH, D
    CHEST, 1989, 95 (03) : S197 - S198
  • [7] A MEMBRANE-BOUND PRECURSOR BETA-LACTAMASE IN STRAINS OF MORAXELLA-CATARRHALIS AND MORAXELLA-NONLIQUEFACIENS THAT PRODUCE PERIPLASMIC BRO-1 AND BRO-2 BETA-LACTAMASES
    STEINGRUBE, VA
    WALLACE, RJ
    BEAULIEU, D
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 (02) : 237 - 244
  • [8] BETA-LACTAMASES OF BRANHAMELLA CATARRHALIS - DISCUSSION
    ROLINSON, GN
    READING, C
    BROOK, I
    LABIA, R
    ELIASSON, I
    SHURIN, PA
    JONES, R
    DRUGS, 1986, 31 : 82 - 82
  • [10] Evaluation of restriction endonuclease analysis of BRO beta-lactamases in clinical and carrier isolates of Moraxella catarrhalis
    Köseoglu, Ö
    Ergin, A
    Hascelik, G
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2004, 36 (6-7) : 431 - 434